SCHEMBL26077209

SCHEMBL26077209

CS(=O)(=O)OCc1cc(Oc2cnc(N3CCCCC3)nc2)nc(-c2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26077213 1.00 FURIN (0.54) FURIN
SCHEMBL26077225 0.94 FURIN (0.49) FURIN
SCHEMBL21550924 0.92 FURIN (0.62) FURIN
SCHEMBL26077250 0.91 FURIN (0.55) FURIN
SCHEMBL26077256 0.90 FURIN (0.52) FURIN
SCHEMBL27032722 0.89 FURIN (0.57) FURIN
SCHEMBL26077219 0.88 FURIN (0.53) FURIN
SCHEMBL26077228 0.88 FURIN (0.43) FURIN
SCHEMBL26077239 0.87 FURIN (0.42) FURIN
SCHEMBL29890774 0.86 FURIN (0.52) FURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 FURIN 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback